THE ROLE OF TP53 MUTATIONS IN LOW-RISK MDS PATIENTS

被引：0
|
作者：
Belickova, M. [1 ]
Vesela, J. [1 ]
Jonasova, A. [2 ]
Kohlmann, A. [3 ]
Stara, E. [1 ]
Planetova, B. [1 ]
Valka, J. [1 ]
Zemanova, Z. [2 ]
Brezinova, J. [1 ]
Michalova, K. [1 ,2 ]
Cermak, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[2] Gen Univ Hosp, Prague, Czech Republic
[3] Munich Leukemia Lab, Munich, Germany
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P320
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [31] CLINICAL IMPACT OF TP53 MUTATIONS IN MDS IN YOUNG ADULTS ACCORDING TO THEIR ALLELIC STATUS
    Irene, Gamez
    Hua, Chen Liang Tzu
    Tornel Salvador, Carrillo
    Alessandro, Liquori
    Balsera Marta, Santiago
    Rosa, Cifuentes
    Mariam, Ibanez
    Leonor, Senent
    Francisco Jose, Ortuno
    Esperanza, Such
    Jose, Cervera
    Raul, Teruel-Montoya
    Guillermo, Sanz
    Andres, Jerez
    HAEMATOLOGICA, 2021, 106 (10) : 101 - 102
  • [32] Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network
    Rossi, Marianna
    Croci, Giorgio
    Boveri, Emanuela
    Gianelli, Umberto
    Ponzoni, Maurilio
    Giordano, Laura
    Ubezio, Marta
    Travaglino, Erica
    Morabito, Lucio
    Milanesi, Chiara
    Saba, Elena
    Borin, Lorenza
    Bernardi, Massimo
    Santini, Valeria
    Voso, Maria Teresa
    Fenu, Susanna
    Orazi, Attilio
    Santoro, Armando
    Bacigalupo, Andrea
    Rambaldi, Alessandro
    Della Porta, Matteo Giovanni
    BLOOD, 2017, 130
  • [33] TP53 mutations in myelodysplastic syndrome
    Misawa, S
    Horiike, S
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 417 - 422
  • [34] Landscape of TP53 Mutations in MPN
    Farnoud, Noushin
    Famulare, Christopher
    Papaemmanuil, Elli
    McGovern, Erin
    Medina, Juan
    Ossa, Juan E. Arango
    Rampal, Raajit K.
    Li, Bing
    Levine, Ross L.
    Mascarenhas, John
    Weinberg, Rona Singer
    Patel, Minal A.
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [35] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [36] TP53 mutations in human meningiomas
    Verheijen, FM
    Sprong, M
    Kloosterman, JME
    Blaauw, G
    Thijssen, JHH
    Blankenstein, MA
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (01): : 42 - 48
  • [37] Are TP53 mutations all alike?
    Wong, Terrence N.
    Link, Daniel C.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2024, (01) : 321 - 325
  • [38] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [39] TP53 mutations sensitize to decitabine
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2017, 14 : 72 - 72
  • [40] INITIALLY AND NEWLY ACQUIRED TP53 MUTATIONS IN PATIENTS WITH MDS WITH DEL(5Q) WITH/WITHOUT LENALIDOMIDE
    Ganster, C.
    Eder, L.
    Rittscher, K.
    Brzuszkiewicz, E.
    Braulke, F.
    Glass, B.
    Elmaagacli, A.
    Mazzeo, P.
    Shirneshan, K.
    Haase, D.
    LEUKEMIA RESEARCH, 2023, 128
12345